Literature DB >> 25432809

Histopathology of the lepromatous skin biopsy.

Cesare Massone1, Workalemahu Alemu Belachew2, Antonio Schettini3.   

Abstract

The histopathology of lepromatous skin varies according to the cell-mediated immunity of the host against Mycobacterium leprae. In tuberculoid and borderline tuberculoid leprosy, epithelioid noncaseating granulomas predominate, and acid-fast bacilli (AFB) are absent or only rarely present. In borderline lepromatous and lepromatous leprosy, the infiltrate is composed of macrophages with a vacuolar cytoplasm, lymphocytes, and plasma cells. AFB are numerous. Edema inside and outside the epithelioid granulomas, together with the appearance of large giant cells, are the main features of type 1 reactions. A conspicuous neutrophilic infiltrate in the subcutis with or without vasculitis is found in erythema nodosum leprosum. The main histopathologic features of leprosy and its particular forms are discussed in this review.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 25432809     DOI: 10.1016/j.clindermatol.2014.10.003

Source DB:  PubMed          Journal:  Clin Dermatol        ISSN: 0738-081X            Impact factor:   3.541


  11 in total

1.  Involvement of TNF-Producing CD8+ Effector Memory T Cells with Immunopathogenesis of Erythema Nodosum Leprosum in Leprosy Patients.

Authors:  Pedro Henrique L Silva; Luciana N Santos; Mayara A Mendes; José A C Nery; Euzenir N Sarno; Danuza Esquenazi
Journal:  Am J Trop Med Hyg       Date:  2019-02       Impact factor: 2.345

2.  Tuberculoid leprosy: An in vivo microvascular evaluation of cutaneous lesions.

Authors:  Livia Pino; Maria das Graças Coelho de Souza; Omar Lupi; Eliete Bouskela
Journal:  PLoS One       Date:  2020-01-13       Impact factor: 3.240

3.  Identification of loci associated with pathological outcomes in Holstein cattle infected with Mycobacterium avium subsp. paratuberculosis using whole-genome sequence data.

Authors:  Maria Canive; Gerard Badia-Bringué; Patricia Vázquez; Oscar González-Recio; Almudena Fernández; Joseba M Garrido; Ramón A Juste; Marta Alonso-Hearn
Journal:  Sci Rep       Date:  2021-10-11       Impact factor: 4.379

4.  Facial Tuberculoid Leprosy.

Authors:  Niraj Parajuli; Sujan Shrestha
Journal:  Am J Trop Med Hyg       Date:  2022-03-21       Impact factor: 3.707

Review 5.  Leprosy: A Review of Epidemiology, Clinical Diagnosis, and Management.

Authors:  Kou-Huang Chen; Cheng-Yao Lin; Shih-Bin Su; Kow-Tong Chen
Journal:  J Trop Med       Date:  2022-07-04

6.  Borderline tuberculoid leprosy misdiagnosed as Cheilitis Granulomatosa Miescher: A case report.

Authors:  Seema Sitaula; Aman Mishra; Sanat Chalise; Aakash Mishra
Journal:  Clin Case Rep       Date:  2022-08-09

7.  Serum Levels of Migration Inhibitory Factor (MIF) and In Situ Expression of MIF and Its Receptor CD74 in Lepromatous Leprosy Patients: A Preliminary Report.

Authors:  Marco Alonso Martinez-Guzman; Anabell Alvarado-Navarro; Vidal Delgado-Rizo; Alejandra Garcia-Orozco; Jorge Arturo Mayorga-Rodríguez; Ana Laura Pereira-Suarez; Mary Fafutis-Morris
Journal:  Front Immunol       Date:  2018-02-13       Impact factor: 7.561

8.  Electron Microscopic Study Using Formalin-fixed, Paraffin-embedded Material, with Special Reference to Observation of Microbial Organisms and Endocrine Granules.

Authors:  Yutaka Tsutsumi
Journal:  Acta Histochem Cytochem       Date:  2018-04-19       Impact factor: 1.938

9.  Optimizing Investigations for Evaluation of Enlargements of the Roots, Plexuses and Nerves: A Study of 133 Patients.

Authors:  Satish Khadilkar; Narayan Dilip Deshmukh; Neha H Shah; Sunila Jaggi; Khushnuma A Mansukhani; Bhagyadhan Patel; Sonali Shah; Sarika Patil; Vanaja Shetty
Journal:  Ann Indian Acad Neurol       Date:  2019-12-06       Impact factor: 1.383

10.  Challenging diagnosis of leprosy in a psychotic homeless patient with atypical clinical manifestations: an interesting case report.

Authors:  Hendra Gunawan; Reyshiani Johan; Pati Aji Achdiat; Oki Suwarsa
Journal:  BMC Infect Dis       Date:  2021-06-07       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.